Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.01417
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA